Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02168062Phase 2Terminated
Phase 2, randomised, open-label trial (2 arms), sponsored by University of California, San Francisco. Primary endpoints: Absolute Change in Percentage Body Fat Mass at 12 months and Percentage of Participants in the Non-randomized Pilot Cohort Who Completed Clinic Visits at 12 months. Started Jun 2014; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02168062.